SynthesisThe Cochrane database of systematic reviews2019

Target of rapamycin inhibitors (TOR-I; sirolimus and everolimus) for primary immunosuppression in kidney transplant recipients.

Deirdre Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.